RS54716B1 - Heterociklična jedinjenja i njihova primena - Google Patents

Heterociklična jedinjenja i njihova primena

Info

Publication number: RS54716B1
Authority: RS; Serbia
Prior art keywords: inflammatory; compound according; pharmaceutically acceptable; mmol; disorders
Prior art date: 2012-04-04

Application number

RS20160272A

Other languages

English (en)

Serbian (sr)

Inventor

Minna Hue Thanh Bui

Timothy D. Cushing

Felix Gonzalez Lopez De Turiso

Xiaolin Hao

Brian Lucas

Original Assignee

Amgen Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-04-04

Filing date

2013-04-04

Publication date

2016-08-31

2013-04-04 Application filed by Amgen Inc. filed Critical Amgen Inc.

2016-08-31 Publication of RS54716B1 publication Critical patent/RS54716B1/sr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

RS20160272A 2012-04-04 2013-04-04 Heterociklična jedinjenja i njihova primena RS54716B1 (sr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261620270P	2012-04-04	2012-04-04
PCT/US2013/035203 WO2013152150A1 (fr)	2012-04-04	2013-04-04	Composés hétérocycliques et leurs utilisations

Publications (1)

Publication Number	Publication Date
RS54716B1 true RS54716B1 (sr)	2016-08-31

Family

ID=48142975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
RS20160272A RS54716B1 (sr)	2012-04-04	2013-04-04	Heterociklična jedinjenja i njihova primena

Country Status (31)

Country	Link
US (2)	US8716290B2 (fr)
EP (1)	EP2834231B1 (fr)
JP (1)	JP2015512451A (fr)
KR (1)	KR20140139547A (fr)
CN (1)	CN104395305A (fr)
AP (1)	AP3611A (fr)
AU (1)	AU2013243506A1 (fr)
CA (1)	CA2869413A1 (fr)
CL (1)	CL2014002686A1 (fr)
CO (1)	CO7091181A2 (fr)
CR (1)	CR20140503A (fr)
CY (1)	CY1117487T1 (fr)
DK (1)	DK2834231T3 (fr)
EA (1)	EA201491823A1 (fr)
ES (1)	ES2577109T3 (fr)
HR (1)	HRP20160352T1 (fr)
HU (1)	HUE028762T2 (fr)
IL (1)	IL234822A0 (fr)
MA (1)	MA37472A1 (fr)
ME (1)	ME02473B (fr)
MX (1)	MX2014011970A (fr)
PE (1)	PE20142457A1 (fr)
PH (1)	PH12014502246A1 (fr)
PL (1)	PL2834231T3 (fr)
RS (1)	RS54716B1 (fr)
SG (1)	SG11201406316VA (fr)
SI (1)	SI2834231T1 (fr)
SM (1)	SMT201600211B (fr)
TN (1)	TN2014000412A1 (fr)
WO (1)	WO2013152150A1 (fr)
ZA (1)	ZA201407037B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2013005567A (es) *	2010-11-17	2013-10-30	Amgen Inc	Derivados de quinolina como inhibidores de pik3.
ME02473B (fr) *	2012-04-04	2017-02-20	Amgen Inc	Composés hétérocycliques et leurs utilisations
WO2015171725A1 (fr)	2014-05-06	2015-11-12	Amgen Inc.	Formes hydratées, cristallines hydratées et cristallines anhydres de la n-((1s)-1-(7-fluoro-2-(2-pyridinyl)-3-quinolinyl)éthyl)-9h-purine-6-amine, compositions pharmaceutiques en contenant et méthodes de traitement du cancer
HK1232227A1 (zh)	2014-07-04	2018-01-05	Lupin Limited	作为pi3k抑制剂的喹嗪酮衍生物
US9637488B2 (en)	2015-01-29	2017-05-02	Fuqiang Ruan	Heterocyclic compounds as inhibitors of class I PI3KS
EP3400227B1 (fr) *	2016-03-05	2021-03-31	Hangzhou Zhengxiang Pharmaceuticals Co., Ltd.	Analogues de quinoléine en tant qu'inhibiteurs de phosphatidylinositol 3-kinase
TW201813963A (zh)	2016-09-23	2018-04-16	美商基利科學股份有限公司	磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh)	2016-09-23	2018-07-16	美商基利科學股份有限公司	磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh)	2016-09-23	2018-05-01	美商基利科學股份有限公司	磷脂醯肌醇3-激酶抑制劑
TWI853009B (zh) *	2019-03-29	2024-08-21	瑞士商先正達農作物保護公司	殺有害生物活性之二-醯胺化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT72878B (en)	1980-04-24	1983-03-29	Merck & Co Inc	Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US6043062A (en)	1995-02-17	2000-03-28	The Regents Of The University Of California	Constitutively active phosphatidylinositol 3-kinase and uses thereof
GB9611460D0 (en)	1996-06-01	1996-08-07	Ludwig Inst Cancer Res	Novel lipid kinase
US5858753A (en)	1996-11-25	1999-01-12	Icos Corporation	Lipid kinase
US5822910A (en)	1997-10-02	1998-10-20	Shewmake; I. W.	Fishing line tensioning device
EP1763526B1 (fr) *	2004-06-28	2009-06-24	Bayer Schering Pharma AG	Pyrimidines 4,6-disubstituees et leur utilisation comme inhibiteurs des proteines kinases
EP2139882B1 (fr) *	2007-03-23	2013-12-25	Amgen Inc.	Dérivés de quinoléine ou quinoxaline 3-substituée et leur utilisation en tant qu'inhibiteurs de phosphatidylinositol 3-kinase (pi3k)
EP2231641B1 (fr) *	2007-12-21	2016-06-01	UCB Biopharma SPRL	Dérivés de quinoxaline et de quinoléine en tant qu'inhibiteurs de kinase
WO2010065923A2 (fr) *	2008-12-04	2010-06-10	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Médicaments à ciblage phosphatidylinositol-3-kinase p110 delta dans le traitement des troubles du snc
SG176986A1 (en) *	2009-06-25	2012-02-28	Amgen Inc	Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
MX2012006953A (es) *	2009-12-18	2012-10-09	Amgen Inc	Compuestos heterociclicos y sus usos.
MX2012015134A (es) *	2010-07-02	2013-05-06	Amgen Inc	Compuestos heterociclicos y su uso como inhibidores de actividad de pi3k.
ME02473B (fr) *	2012-04-04	2017-02-20	Amgen Inc	Composés hétérocycliques et leurs utilisations

2013
- 2013-04-04 ME MEP-2016-61A patent/ME02473B/fr unknown
- 2013-04-04 AP AP2014007979A patent/AP3611A/xx active
- 2013-04-04 RS RS20160272A patent/RS54716B1/sr unknown
- 2013-04-04 CN CN201380017551.2A patent/CN104395305A/zh active Pending
- 2013-04-04 HR HRP20160352TT patent/HRP20160352T1/hr unknown
- 2013-04-04 SI SI201330170A patent/SI2834231T1/sl unknown
- 2013-04-04 WO PCT/US2013/035203 patent/WO2013152150A1/fr not_active Ceased
- 2013-04-04 US US13/856,500 patent/US8716290B2/en active Active
- 2013-04-04 EP EP13717655.8A patent/EP2834231B1/fr active Active
- 2013-04-04 DK DK13717655.8T patent/DK2834231T3/en active
- 2013-04-04 AU AU2013243506A patent/AU2013243506A1/en not_active Abandoned
- 2013-04-04 CA CA2869413A patent/CA2869413A1/fr not_active Abandoned
- 2013-04-04 MX MX2014011970A patent/MX2014011970A/es unknown
- 2013-04-04 PE PE2014001529A patent/PE20142457A1/es not_active Application Discontinuation
- 2013-04-04 PL PL13717655T patent/PL2834231T3/pl unknown
- 2013-04-04 EA EA201491823A patent/EA201491823A1/ru unknown
- 2013-04-04 SG SG11201406316VA patent/SG11201406316VA/en unknown
- 2013-04-04 ES ES13717655.8T patent/ES2577109T3/es active Active
- 2013-04-04 HU HUE13717655A patent/HUE028762T2/en unknown
- 2013-04-04 MA MA37472A patent/MA37472A1/fr unknown
- 2013-04-04 KR KR1020147028346A patent/KR20140139547A/ko not_active Withdrawn
- 2013-04-04 JP JP2015504713A patent/JP2015512451A/ja not_active Ceased
2014
- 2014-03-21 US US14/221,499 patent/US8835432B2/en active Active
- 2014-09-23 IL IL234822A patent/IL234822A0/en unknown
- 2014-09-26 ZA ZA2014/07037A patent/ZA201407037B/en unknown
- 2014-09-30 TN TNP2014000412A patent/TN2014000412A1/fr unknown
- 2014-10-03 CL CL2014002686A patent/CL2014002686A1/es unknown
- 2014-10-03 PH PH12014502246A patent/PH12014502246A1/en unknown
- 2014-10-07 CO CO14222148A patent/CO7091181A2/es unknown
- 2014-10-30 CR CR20140503A patent/CR20140503A/es unknown
2016
- 2016-04-26 CY CY20161100347T patent/CY1117487T1/el unknown
- 2016-07-05 SM SM201600211T patent/SMT201600211B/it unknown

Also Published As

Publication number	Publication date
CL2014002686A1 (es)	2015-05-08
US8835432B2 (en)	2014-09-16
AP2014007979A0 (en)	2014-09-30
CO7091181A2 (es)	2014-10-21
IL234822A0 (en)	2014-12-31
PL2834231T3 (pl)	2016-07-29
KR20140139547A (ko)	2014-12-05
EA201491823A1 (ru)	2015-01-30
US20130267524A1 (en)	2013-10-10
US20140206694A1 (en)	2014-07-24
SG11201406316VA (en)	2014-11-27
ZA201407037B (en)	2015-11-25
US8716290B2 (en)	2014-05-06
ME02473B (fr)	2017-02-20
PE20142457A1 (es)	2015-02-07
HUE028762T2 (en)	2016-12-28
SMT201600211B (it)	2016-08-31
CR20140503A (es)	2015-03-06
AP3611A (en)	2016-02-29
CY1117487T1 (el)	2017-04-26
JP2015512451A (ja)	2015-04-27
CN104395305A (zh)	2015-03-04
SI2834231T1 (sl)	2016-09-30
DK2834231T3 (en)	2016-04-18
TN2014000412A1 (en)	2015-12-21
CA2869413A1 (fr)	2013-10-10
EP2834231B1 (fr)	2016-03-30
AU2013243506A1 (en)	2014-10-09
MA37472A1 (fr)	2016-09-30
HRP20160352T1 (hr)	2016-05-06
MX2014011970A (es)	2015-05-12
PH12014502246A1 (en)	2014-12-15
EP2834231A1 (fr)	2015-02-11
WO2013152150A1 (fr)	2013-10-10
ES2577109T3 (es)	2016-07-13

Publication	Publication Date	Title
CA2680783C (fr)	2012-04-24	Composes heterocycliques et leurs utilisations
EP2445900B1 (fr)	2016-03-02	Derives polycycliques de pyridine et leur utilisation dans le traitement de (entre autres) arthrite rhumatoïde et de troubles similaires
CA2680853C (fr)	2012-07-17	Derives de quinoleine ou quinoxaline 3-substituee et leur utilisation en tant qu'inhibiteurs de phosphatidylinositol 3-kinase (pi3k)
EP2137186B1 (fr)	2016-01-27	Composés hétérocycliques et leurs utilisations
EP2588468B1 (fr)	2014-03-26	Composés hétérocycliques et leur utilisation comme inhibiteurs de l'activité pi3 k
DK2834231T3 (en)	2016-04-18	HETEROCYCLIC COMPOUNDS AND THEIR USES
EP2640715A1 (fr)	2013-09-25	Dérivés de quinoléine en tant qu'inhibiteurs de pi3k
EP2588467A1 (fr)	2013-05-08	Composés hétérocycliques et leur utilisation comme inhibiteurs de l'activité de pi3k
WO2012061696A1 (fr)	2012-05-10	Dérivés de la 5-cyano-4,6-diaminopyrimidine ou de la 6-aminopurine en tant qu'inhibiteurs de la pi3k-delta
WO2012003264A1 (fr)	2012-01-05	Composés hétérocycliques contenant de l'azote comme inhibiteurs de pi3k-delta